A lot of the losses for this HY 2019 were in setting up INCANNEX, one off expenses and buying the shipment of oils that hasnt translated into revenues yet because those revenues are coming in Q1 and Q2 2020.
The Peloton CR was to accelerate/fasttrack the trials which at least two will happen this year for certain.
No need for another CR for at least another year IMO. And by then, the company will have either "make it or break it".
There really isn't anything we didn't already know in this report. Its HY for Second Half of 2019...
